AstraZeneca Newsroom

Here Are Morgan Stanley's Key Oncology Catalysts for 2025

Seeking AlphaDec 28 10:31 ET

Astrazeneca (AZN) Stock Moves -0.39%: What You Should Know

Yahoo FinanceDec 27 18:15 ET

Daiichi Sankyo Gets Japanese Approval for Datroway

Seeking AlphaDec 27 10:52 ET

Here's Why Astrazeneca (AZN) Is a Strong Value Stock

Yahoo FinanceDec 27 09:40 ET

Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts

RTTNewsDec 27 02:12 ET

Achilles Therapeutics Sells Key Assets to AstraZeneca

TipRanksDec 27 02:08 ET

Orient: Initiated a "Buy" rating for Hutchmed (China) with a Target Price of HKD 33.24.

Orient issued a research report predicting that Hutchmed (China) (00013) will have revenue of 680 million, 844 million, and 1 billion USD for 2024-2026, respectively. Based on comparable companies, a 4.4 times PS is given for the company in 2025, corresponding to a Target Price of 33.24 HKD, with an initial 'Buy' rating. Orient's main points are as follows: a Global layout of small molecule Innovative Drugs. The company was founded in 2000, and after more than twenty years of deep cultivation in the small molecule oncology field, it has three commercialized products and several late-stage clinical drugs, accumulating rich experience in commercial Operation, and partnering with...

Sina Hong Kong StockDec 26 21:27 ET

AstraZeneca Withdraws Lung Cancer Drug Application in EU

TipRanksDec 26 11:27 ET

AZN, Daiichi Withdraw EU Filing for Dato-DXd in Nonsquamous NSCLC

Zacks Dec 26 09:35 ET

Achievements and Progress Heading Into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

GlobeNewswireDec 26 09:00 ET

AstraZeneca's (LON:AZN) Investors Will Be Pleased With Their Respectable 55% Return Over the Last Five Years

Yahoo FinanceDec 26 01:13 ET

ROSEN, LEADING INVESTOR COUNSEL Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN

newsfileDec 25 21:55 ET

AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe Into Fraud and Corruption - Hagens Berman

newsfileDec 25 12:03 ET

AstraZeneca, Daiichi Sankyo Have Voluntarily Withdrawn a Dato-DXd MAA in EU

Yahoo FinanceDec 25 05:10 ET

AstraZeneca PLC ADR Underperforms Tuesday When Compared To Competitors

MarketWatchDec 24 17:29 ET

Achilles Therapeutics Transfers TRACERx Data and MAP Assets to AstraZeneca in $12M Agreement

Quiver QuantitativeDec 24 09:41 ET

Express News | Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions

BenzingaDec 24 09:31 ET

Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

Dow JonesDec 24 09:30 ET

London Shares Festive Ahead of Christmas Break; Vistry Slumps on Fresh Profit Warning

MT NewswiresDec 24 07:48 ET

AstraZeneca Pulls EU Marketing Application for Lung Cancer Treatment Amid Regulatory Feedback

MT NewswiresDec 24 05:41 ET